Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Orphazyme A/S (CO: ORPHA)

 
ORPHA Technical Analysis
5
As on 11th Jul 2023 ORPHA SHARE Price closed @ 1.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.51 & Strong Sell for SHORT-TERM with Stoploss of 9.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ORPHASHARE Price

Open 1.56 Change Price %
High 1.56 1 Day -0.34 -21.94
Low 1.21 1 Week -0.46 -27.54
Close 1.21 1 Month -1.05 -46.46
Volume 267865 1 Year -11.90 -90.77
52 Week High 15.98 | 52 Week Low 0.76
 
CO Denmark Most Active Stocks
SAS-DKK 0.23 0.00%
SAS 0.23 0.00%
TRYG 134.80 -6.62%
AMBU-B 103.75 -4.38%
VWS 179.82 2.07%
NOVO-B 1034.60 -2.56%
ALMB 11.09 -0.54%
GREENH 10.50 1.94%
DANSKE 166.10 1.10%
BLVIS-A 0.40 -18.37%
 
CO Denmark Top Gainers Stocks
NORD 2.10 19.32%
NORD 2.10 19.32%
DKIEEU 249.00 15.81%
HYDRCT 1.69 10.46%
TGAMES 4.37 9.25%
ENALYZ 2.50 8.70%
ODICO 1.53 6.25%
CEMAT 0.71 5.97%
VIRO 22.10 5.24%
VALUER 0.21 5.00%
 
CO Denmark Top Losers Stocks
ASTRLS 1.07 -38.15%
ORPHA 1.21 -21.94%
BLVIS-A 0.40 -18.37%
LEDIBOND 0.40 -11.11%
ERRIA 4.15 -8.39%
HYPE 3.06 -8.38%
TRYG 134.80 -6.62%
NTR-B 6.40 -6.43%
HAPPY 0.18 -5.26%
STENO 3.87 -4.68%
 
 
ORPHA
Daily Charts		 ORPHA
Intraday Charts		 Whats New @
Bazaartrend		 ORPHA
Free Analysis
 
ORPHA Important Levels Intraday
RESISTANCE1.88
RESISTANCE1.67
RESISTANCE1.53
RESISTANCE1.40
SUPPORT1.02
SUPPORT0.89
SUPPORT0.75
SUPPORT0.54
 
ORPHA Forecast April 2024
Share
4th UP Forecast26.51
3rd UP Forecast18.4
2nd UP Forecast13.38
1st UP Forecast8.37
1st DOWN Forecast-5.95
2nd DOWN Forecast-10.96
3rd DOWN Forecast-15.98
4th DOWN Forecast-24.09
 
ORPHA Weekly Forecast
4th UP Forecast4.58
3rd UP Forecast3.50
2nd UP Forecast2.83
1st UP Forecast2.16
1st DOWN Forecast0.26
2nd DOWN Forecast-0.41
3rd DOWN Forecast-1.08
4th DOWN Forecast-2.16
 
ORPHA Forecast2024
4th UP Forecast32.62
3rd UP Forecast22.55
2nd UP Forecast16.32
1st UP Forecast10.09
1st DOWN Forecast-7.67
2nd DOWN Forecast-13.9
3rd DOWN Forecast-20.13
4th DOWN Forecast-30.2
 
 
ORPHA Other Details
Segment EQ
Market Capital 908757184.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ORPHA Address
ORPHA
 
ORPHA Latest News
 
Your Comments and Response on Orphazyme A/S
 
ORPHA Business Profile
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Address: Ole MaalOees Vej 3, Copenhagen, Denmark, 2200
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service